TREA

88768179 - PINPOINT

Follow

Information

  • Trademark
  • 88768179
  • Serial Number
    88768179
  • Registration Number
    6325211
  • Filing Date
    January 21, 2020
    5 years ago
  • Registration Date
    April 20, 2021
    3 years ago
  • Transaction Date
    July 12, 2024
    7 months ago
  • Status Date
    April 20, 2021
    3 years ago
  • Published for Opposition Date
    February 02, 2021
    4 years ago
  • Location Date
    April 20, 2021
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    MALYSZEK, KIMBERLY RAY
  • Attorney Name
    Kevin A. Oliver
    Law Office Assigned Location Code
    N40
  • Owners
Information
Mark Drawing Code
4
Mark Identification
PINPOINT
Case File Statements
  • GS0401: Treatment of biopharmaceutical materials; custom manufacture of cells and vectors for diagnostic, medical and commercial applications in relation to cell and gene therapies; consultancy and advisory services relating to the aforesaid services
  • GS0091: collections of DNA and gene sequences for research and reference purposes provided as DNA microarrays and DNA chips
  • GS0051: Diagnostic preparations and materials generated by the use of base editing components for medical purposes; chemical preparation for use in DNA analysis for medical purposes; biological preparations in the nature of DNA, RNA and parts thereof for medical purposes; biological preparations in the nature of DNA extracts for medical purposes; biological preparations in the nature of gene editing enzymes for medical purposes; biological preparations in the nature of protein cell lysates, genomic DNA preparations and Formalin Fixed, Paraffin Embedded (FFPE) engineered tumour tissue mimics for medical diagnostic use; biological preparations in the nature of biological, biochemical and chemical reagents, including living cells, genetically modified cells and vectors, genomic DNA, cell cultures and mutant and normal isogenic cell line pairs, peptides, proteins and nucleic acids or complexes of these molecules for medical use; all the aforesaid goods being medical preparations
  • GS0011: Biological preparations in the nature of eukaryotic cells, isogenic cell lines and bio-production cell lines generated using base editing engineering for scientific, laboratory or medical research; reagents, plasmids and assays for scientific, genetic and medical research; genomic reference control samples for medical laboratory use; molecular biology research tools, in the nature of chemical, biological and biochemical reagents; biological preparations in the nature of separate base editing components including mRNA, rRNA, gRNA, deaminase, nickase, ribonucleotide protein (RNP) for use in scientific, laboratory or medical research; biological preparations in the nature of genetically modified cells and vectors for scientific and research purposes; biological and chemical reagents including complexes of these molecules for research and for clinical and industrial use
  • GS0421: Custom cell-line engineering services; gene base-editing services for research purposes; gene engineering services; research and development services in the creation of databases or collections of information on biologicals including cells and cell lines for research purposes; creating and providing databases or collections of information on normal and mutated genes for research purposes; providing DNA reference standards for research purposes; providing DNA reference databases being collections of DNA and gene sequences for research purposes; research on cell line models; contract research on cell line models; research and development services relating to targeting therapies to individuals; establishing patient genotypes for research or analysis purposes; research and development services relating to combining therapies for individuals; research and development relating to reagents; disease modelling for research purposes; design of clinical trials for research purposes; research and development in re-positioning existing drugs from other therapeutic indications; consultancy and advisory services relating to the aforesaid services; all of the aforesaid services relating to biological and medical research and research and development in the field of cells and cell therapies, genome editing, genetic engineering and gene therapies
Case File Event Statements
  • 1/24/2020 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 1/25/2020 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/20/2020 - 4 years ago
    3 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 3/30/2020 - 4 years ago
    5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 3/26/2020 - 4 years ago
    4 - ASSIGNED TO LIE Type: ALIE
  • 9/26/2020 - 4 years ago
    13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/8/2020 - 4 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/9/2020 - 4 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/9/2020 - 4 years ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 4/9/2020 - 4 years ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/4/2020 - 4 years ago
    10 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 6/4/2020 - 4 years ago
    12 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 6/4/2020 - 4 years ago
    11 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 9/26/2020 - 4 years ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/28/2020 - 4 years ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/29/2020 - 4 years ago
    18 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/29/2020 - 4 years ago
    16 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/29/2020 - 4 years ago
    17 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 12/26/2020 - 4 years ago
    19 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/26/2020 - 4 years ago
    20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/26/2020 - 4 years ago
    21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/28/2020 - 4 years ago
    22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/2/2021 - 4 years ago
    24 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/13/2021 - 4 years ago
    23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/2/2021 - 4 years ago
    25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/12/2024 - 7 months ago
    28 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 7/12/2024 - 7 months ago
    33 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 7/12/2024 - 7 months ago
    29 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 7/12/2024 - 7 months ago
    27 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 7/12/2024 - 7 months ago
    31 - TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED Type: EWOR
  • 7/12/2024 - 7 months ago
    30 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 7/12/2024 - 7 months ago
    32 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 4/20/2021 - 3 years ago
    26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR